Aileron Therapeutics Statistics

Total Valuation

ALRN has a market cap or net worth of $80.45 million. The enterprise value is $63.16 million.

Market Cap	80.45M
Enterprise Value	63.16M

Important Dates

The last earnings date was Monday, April 15, 2024, after market close.

Earnings Date	Apr 15, 2024
Ex-Dividend Date	n/a

Share Statistics

ALRN has 16.97 million shares outstanding. The number of shares has increased by 1.31% in one year.

Shares Outstanding	16.97M
Shares Change (YoY)	+1.31%
Shares Change (QoQ)	+5.07%
Owned by Insiders (%)	0.20%
Owned by Institutions (%)	18.19%
Float	16.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	11.68
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.17, with a Debt / Equity ratio of 0.01.

Current Ratio	4.17
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -139.40% and return on invested capital (ROIC) is -234.69%.

Return on Equity (ROE)	-139.40%
Return on Assets (ROA)	-42.00%
Return on Capital (ROIC)	-234.69%
Revenue Per Employee	n/a
Profits Per Employee	-$2.62M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +204.88% in the last 52 weeks. The beta is 2.24, so ALRN's price volatility has been higher than the market average.

Beta (1Y)	2.24
52-Week Price Change	+204.88%
50-Day Moving Average	5.36
200-Day Moving Average	3.00
Relative Strength Index (RSI)	44.34
Average Volume (30 Days)	63,514

Short Selling Information

The latest short interest is 35,341, so 0.21% of the outstanding shares have been sold short.

Short Interest	35,341
Short Previous Month	32,951
Short % of Shares Out	0.21%
Short % of Float	0.21%
Short Ratio (days to cover)	1.04

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-16.28M
Pretax Income	-15.73M
Net Income	-15.73M
EBITDA	-15.61M
EBIT	-15.73M
Earnings Per Share (EPS)	-$3.42

Full Income Statement

Balance Sheet

The company has $17.34 million in cash and $48,000 in debt, giving a net cash position of $17.29 million or $1.02 per share.

Cash & Cash Equivalents	17.34M
Total Debt	48,000
Net Cash	17.29M
Net Cash Per Share	$1.02
Equity / Book Value	6.89M
Book Value Per Share	0.41
Working Capital	13.88M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$19.81 million and capital expenditures $42,000, giving a free cash flow of -$19.77 million.

Operating Cash Flow	-19.81M
Capital Expenditures	42,000
Free Cash Flow	-19.77M
FCF Per Share	-$4.30

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ALRN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.31%
Shareholder Yield	-1.31%
Earnings Yield	-19.56%
FCF Yield	-24.57%

Analyst Forecast

The average price target for ALRN is $19.00, which is 300.84% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.00
Price Target Difference	300.84%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 11, 2022. It was a reverse split with a ratio of 1:20.

Last Split Date	Nov 11, 2022
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a